
Inflation Reduction Act Leads to Seesaw Effect Between Oncologic Drug Savings and Development
The Inflation Reduction Act (IRA), which was signed into law in 2022, contains provisions designed to lower drug prices for Medicare beneficiaries.1 Although significant savings have already been reported,2 the legislation may have unintended consequences …